These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10901022)

  • 1. [Rheumatoid arthritis. Genetics and histocompatibility].
    Balsa A; Pascual-Salcedo D; Martín Mola E
    Rev Clin Esp; 2000 May; 200 Monog 1():20-4. PubMed ID: 10901022
    [No Abstract]   [Full Text] [Related]  

  • 2. [Genetic aspects of rheumatoid arthritis].
    Dieudé P
    Rev Prat; 2005 Dec; 55(19):2143-5. PubMed ID: 16594119
    [No Abstract]   [Full Text] [Related]  

  • 3. Rheumatoid arthritis XII: epidemiology and genetics.
    Hochberg MC; Arnett FC
    Md State Med J; 1983 May; 32(5):365-7. PubMed ID: 6306359
    [No Abstract]   [Full Text] [Related]  

  • 4. Histocompatibility antigens of patients with rheumatoid arthritis.
    Brackertz D; Mueller-Eckhardt C; Heinrich D; Kueppers F; Schulz G; Kretschmer V
    Z Immunitatsforsch Exp Klin Immunol; 1973 Nov; 146(2):108-13. PubMed ID: 4143164
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunogenetics of rheumatoid arthritis].
    Galeazzi M
    Clin Ter; 1991 Dec 15-31; 139(5-6):203-7. PubMed ID: 1724952
    [No Abstract]   [Full Text] [Related]  

  • 6. Patients chosen for treatment with cyclosporine because of severe rheumatoid arthritis are more likely to carry HLA-DRB1 shared epitope alleles, and have earlier disease onset.
    González-Gay MA; Hajeer AH; García-Porrúa C; Dababneh A; Thomson W; Ollier WE; Mattey DL
    J Rheumatol; 2002 Feb; 29(2):271-5. PubMed ID: 11842822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linkage studies in sulfoxidation status, HLA and rheumatoid arthritis.
    Deighton CM; Ayesh R; Walker DJ; Panayi GS
    J Rheumatol; 1990 Nov; 17(11):1562-3. PubMed ID: 2273505
    [No Abstract]   [Full Text] [Related]  

  • 8. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
    Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
    J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HLA genomic tissue typing in myasthenic patients with rheumatoid arthritis].
    Varga E; Varga E; Jáger R; Petró A; Gyódi E; Bálint G; Náfrádi L; Varga L
    Orv Hetil; 2001 Oct; 142(41):2255-7. PubMed ID: 11760469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translating genetic information into clinical disease risk in rheumatoid arthritis.
    Macgregor AJ; Steer SE
    J Rheumatol; 2006 Dec; 33(12):2376-8. PubMed ID: 17143976
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis and predictor of an erosive disease.
    Orbach H; Gilburd B; Brickman CM; Gerli R; Shoenfeld Y
    Isr Med Assoc J; 2002 Nov; 4(11 Suppl):892-3. PubMed ID: 12455175
    [No Abstract]   [Full Text] [Related]  

  • 12. Soluble HLA-G in rheumatoid arthritis.
    Verbruggen LA; Rebmann V; Demanet C; De Cock S; Grosse-Wilde H
    Hum Immunol; 2006 Aug; 67(8):561-7. PubMed ID: 16916651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rheumatoid arthritis and HLA antigens].
    Benevolebskaia LI; Tananov AT; Kut'ina RM; Alekseeva LI; Orlov-Morozov AV
    Vopr Revm; 1981; (3):8-11. PubMed ID: 7314607
    [No Abstract]   [Full Text] [Related]  

  • 14. Rheumatoid arthritis in Poland and Lithuania: different clinical course and HLA associations despite similar genetic background.
    Płoski R; Butrimiene I; Kamińska E; Valiukiene K; Sliwińska P; Kubasiewicz E; Kozakiewicz A; Smerdel A; Kucinskas V; Jaworski J; Jastrzebska E; Forre O; Venalis A; Pazdur J
    Ann Rheum Dis; 2005 Jan; 64(1):165-6. PubMed ID: 15608325
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles.
    Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK
    Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA antigens in rheumatoid arthritis.
    Panayi GS; Wooley PH; Griffin J; Batchelor JR; Welsh K; Gibson TJ
    Agents Actions Suppl; 1980; 7():66-8. PubMed ID: 6941689
    [No Abstract]   [Full Text] [Related]  

  • 17. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
    Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
    Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic epidemiology of rheumatoid arthritis.
    Oliver JE; Worthington J; Silman AJ
    Curr Opin Rheumatol; 2006 Mar; 18(2):141-6. PubMed ID: 16462519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of smoking and the HLA-DRB1 shared epitope in rheumatoid factor-positive rheumatoid arthritis: comment on the article by Padyukov et al.
    de Vries N; Zwinderman AH; Tak PP
    Arthritis Rheum; 2005 Nov; 52(11):3676; author reply 3676-8. PubMed ID: 16258907
    [No Abstract]   [Full Text] [Related]  

  • 20. Soluble FcgammaRIIIa as a marker for rheumatoid arthritis: the use of genetics in selected populations to study pathogenetic pathways.
    Huizinga TW; Ioan-Facsinay A
    J Rheumatol; 2003 Sep; 30(9):1904-6. PubMed ID: 12966588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.